GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Careplus Group Bhd (XKLS:0163) » Definitions » Cash Conversion Cycle

Careplus Group Bhd (XKLS:0163) Cash Conversion Cycle : 115.44 (As of Mar. 2025)


View and export this data going back to 2010. Start your Free Trial

What is Careplus Group Bhd Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Careplus Group Bhd's Days Sales Outstanding for the three months ended in Mar. 2025 was 48.
Careplus Group Bhd's Days Inventory for the three months ended in Mar. 2025 was 102.93.
Careplus Group Bhd's Days Payable for the three months ended in Mar. 2025 was 35.49.
Therefore, Careplus Group Bhd's Cash Conversion Cycle (CCC) for the three months ended in Mar. 2025 was 115.44.


Careplus Group Bhd Cash Conversion Cycle Historical Data

The historical data trend for Careplus Group Bhd's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Careplus Group Bhd Cash Conversion Cycle Chart

Careplus Group Bhd Annual Data
Trend Jan13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Jun24
Cash Conversion Cycle
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.19 36.62 57.63 61.27 258.85

Careplus Group Bhd Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Mar23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 58.27 156.06 143.69 155.16 115.44

Competitive Comparison of Careplus Group Bhd's Cash Conversion Cycle

For the Medical Instruments & Supplies subindustry, Careplus Group Bhd's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Careplus Group Bhd's Cash Conversion Cycle Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Careplus Group Bhd's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Careplus Group Bhd's Cash Conversion Cycle falls into.


;
;

Careplus Group Bhd Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Careplus Group Bhd's Cash Conversion Cycle for the fiscal year that ended in Jun. 2024 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=128.8+186.53-56.48
=258.85

Careplus Group Bhd's Cash Conversion Cycle for the quarter that ended in Mar. 2025 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=48+102.93-35.49
=115.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Careplus Group Bhd  (XKLS:0163) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Careplus Group Bhd Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Careplus Group Bhd's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Careplus Group Bhd Business Description

Traded in Other Exchanges
N/A
Address
Off Jalan Senawang 3, Lot 17479, Lorong Senawang 3/2, Senawang Industrial Estate, Seremban, NSN, MYS, 70450
Careplus Group Bhd is involved in the manufacturing, processing, and trading of gloves. The company's product consists of Latex exam gloves, Latex surgical gloves, and Nitrile exam gloves. Its Latex exam gloves are used in medical examinations and procedures, diagnostic procedures by the dentist, laboratory practices, and food handling practices. The Nitrile exam gloves are generally used in laboratory practices and the automotive industry. Geographically, it derives maximum revenue from Malaysia and the rest from North America, South America, Other Asia Pacific regions, and other regions.

Careplus Group Bhd Headlines

No Headlines